In an unpleasant event, less than 100 eligible beneficiaries above 60 years of age in Mumbai have taken world’s first intranasal iNCOVACC vaccine in the last seven days in the city.
This development comes despite rise in the coronavirus cases in the city since past few weeks.
According to the data provided by the public health department of the Brihanmumbai Municipal Corporation (BMC), 75 people have taken iNCOVACC from April 28 to May 4, which means daily 10 to 11 beneficiaries are being administered the nasal vaccine.
Since it is a new vaccine, beneficiaries still hesitate and most of them have completed their booster dose earlier, an official exclaimed.
iNCOVACC was rolled out at government centres after sorting out the glitch in the CoWin app, which was initially not issuing the vaccination certificate to people opting for the vaccine.
On May 4, the city has recorded 96 COVID-19 cases and zero deaths. Moreover, less than 2 per cent of patients are admitted to hospitals across Mumbai.
#कोविडसंसर्ग स्थिती: ४ मे २०२३, सायंकाळी ६ वाजता #CovidUpdates : 4 May 2023, 6pm #कोरोनालाना #NaToCorona #CovidIsntOver pic.twitter.com/yVLVMUMAHc
— माझी Mumbai, आपली BMC (@mybmc) May 4, 2023
Meanwhile, on the same day, Maharashtra reported 361 new cases and four people succumbed in the last 24 hours. The total number of cases has now increased to 81,66,867 with 1,48,532 fatalities till date.
Share
Tweet
